documents: FDA-2026-N-1321-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-1321-0001 | FDA | FDA-2026-N-1321 | ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing | Notice | Withdrawal | 2026-04-30 | 2026 | 4 | 2026-04-30 | 2026-06-30 | 2026-05-16 09:00:16 | 2026-08455 | 1 | 0 | 09000064b92b7e81 |